Connor, Clark & Lunn Investment Management Ltd.

Position in AGEN — Agenus Inc

CIK 1596800 VANCOUVER, A1

Position in AGEN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$948,707

+$285,711 QoQ

Shares Held

310,035

+56.2% QoQ

Ownership

0.689%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#14

of 103 holders

Holding Since

Mar 2020

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $650,455,382 across 105 Biotechnology names. AGEN ranks #66 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	135,236	$67,175,777
2	IONS	Ionis Pharmaceuticals Inc	684,236	$54,253,072
3	ARWR	Arrowhead Pharmaceuticals, Inc.	625,569	$50,990,129
4	MIRM	Mirum Pharmaceuticals, Inc.	420,063	$49,176,775
5	REGN	Regeneron Pharmaceuticals, Inc.	42,465	$26,478,625
6	AXSM	Axsome Therapeutics, Inc.	97,698	$23,913,539
7	INSM	INSMED Inc	212,676	$22,675,515
8	VKTX	Viking Therapeutics, Inc.	530,607	$20,698,979

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$948,707	310,035	+56.2%	Shares	Sole	2026-08-13
2026-03-31	$662,996	198,502	+192.1%	Shares	Sole	2026-05-11
2025-12-31	$213,391	67,959	-5.9%	Shares	Sole	2026-02-10
2024-06-30	$1,209,819	72,228	-80.6%	Shares	Sole	2024-08-09
2024-03-31	$216,149	372,671	+1190.3%	Shares	Sole	2024-05-09
2022-03-31	$71,049	28,882	-96.9%	Shares	Sole	2022-05-12
2021-09-30	$4,903,536	934,007	+430.5%	Shares	Sole	2021-11-12
2020-03-31	$431,384	176,075	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.